January 2011

BMS takes hit in Q4, FY2010, despite sales increases ()
JACC: Younger AF patients suffer more inappropriate ICD shocks ()
JACC: HCTZ poorly reduces BP when compared to all other drugs ()
CMAJ: CRT+medical or defibrillator therapy can reduce mortality ()
JAMA: Stroke risk w/ CABG reduced; personalizing operative techniques helps ()
Abbott posts double-digit sales for Q4 & FY10, announces layoffs ()
St. Jude's CRM, a-fib arms propel its returns for Q4, FY10 ()
JAMA: Can individualized treatment help prevent stroke death? ()
TAVI: Wave of the Future? Or Time for a Deep Breath? ()
Cardiovascular Group, Atlanta | Linking EP Patient Data to the EMR: The Figures Speak for Themselves ()
CMAJ: Restricting ARB use could have saved Canada $77M ()
Bifurcation Lesions: Challenges & Solutions ()
Making Your CVIS Work for You ()
ACC Corner | Personalized Medicine: Next Generation of CV Care? ()
News & Views | ICD use in primary prevention: Do we really know enough? ()
AstraZeneca responds to FDA on ticagrelor ()
Circ: Triple-drug rejection therapy not needed for heart transplant ()
The Back Page | View from the Hospital Practice Survival ()
Circ: Costs to treat heart disease will triple to $818B by 2030 ()
AEM: ED patients with flutter need defibrillation, not drugs ()
Defibrillators for home use could mean revenue growth ()
Study: Fast, inexpensive hypothermia protocol improves post-cardiac arrest ()
EHJ: Danish researchers refine evaluation of SCD in young ()
AHA: Secondary ed students need CPR/AED training to graduate ()
Study assesses earlier use of LVADs in HF ()
AJC Feature: One in 10 DES patients prematurely stop antiplatelet therapy ()
AJR: Abdominal CT often changes diagnosis ()
St. Jude settles kickback suit with DoJ for $16M ()
JACC: No post-MI interaction between Plavix, calcium-channel blockers ()
SCAI: Advice for beginning radialists ()
Heart: Gaping HF death disparity between specialist, general wards ()
Q&A: What to look for at the Interoperability Showcase ()
BAFS: New AF ablation guidelines to weigh real-life practice considerations ()
Boston Sci buys Watchman maker Atritech for up to $375M ()
AIM: High-volume facilities provide better CHF care at a higher cost ()
FDA permits Medtronic to revise CoreValve pivotal trial ()
Q&A: New NeHC director sees unique opportunity ()
BAFS: Better surgeon/EP relations may improve AF ablation outcomes ()
GSK takes $3.4B hit over U.S. Avandia woes ()
Covidien releases updated peripheral stent in EU ()
SCAI: A 12-step program for 'femoral-aholics' ()
JACC: Triple-antiplatelet therapy is no better than dual therapy ()
BAFS: Trial design for AF ablation devices challenge the FDA ()
FDA warning links Multaq to severe liver injury ()
New stroke guidelines: Better data reporting can improve stroke center care ()
BAFS: New anticoagulants may outshine warfarin, but questions remain ()
ISET: Peripheral DES may be safe, effective for leg arteries at two years ()
Lancet: Some genetic profiles increase CAD risk, others increase MI risk ()
Researchers stop Mercks vorapaxar trials, based on DSMB recommendations ()
Circ: Out-of-hospital AMI deaths increase among younger patients ()
MI mortality rates drop, but non-STEMI incidence increases ()
Circ: Simplify bifurcation stenting with no final kissing balloon dilatation ()
Endosense initiates trial for AF catheter ablation ()
Lancet: Combo therapy better reduces BP than monotherapy ()
JAMA: Surgeons may need to reconsider radial artery grafts for CABG ()
NEJM: Cholesterol efflux capacity is inversely related to CIMT, CAD risk ()
Lilly, Boehringer to develop diabetic compounds ()
Circ: CABG open vein harvesting may be 'obsolete' soon ()
Heart: Low survival from prenatal screening sounds alarm ()
Circ: Cardioversion poses equal risk for AF patients on dabigatran, warfarin ()
AngioDynamics books positive Q2 ()
JAMA: ARBs: Is cheaper better? ()
Abbott nabs first CE mark for bioresorbable DES ()
AstraZeneca, Abbott Certriad deal a no go ()
ICD use in primary prevention: Do we really know enough? ()
JAMA: Many ICD implants fall outside guideline recommendations ()
AJR: Image quality linked to pulmonary embolism CAD false positives ()
Circ: Risk-adjusted anticoagulation model improves outcomes ()
AJC: Education key for dual-antiplatelet therapy compliance ()
Study: Prospective triggering cuts CCTA dose ()
NEJM: Team-based approach combats depression linked with chronic diseases ()
JACC: Combining biomarkers, risk factors helps predict mortality ()
Medtronic commences CoreValve trial in U.S. ()
Abbott recalls blood glucose test strips, after false results ()